Skip to content

Effect of intravenous lidocaine on hemodynamics after intraoperative injection of posterior pituitary lobe in patients undergoing laparoscopic uterine myomectomy surgery

Effect of intravenous lidocaine on hemodynamics after intraoperative injection of posterior pituitary lobe in patients undergoing laparoscopic uterine myomectomy surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101771
Enrollment
Unknown
Registered
2025-04-29
Start date
2025-02-20
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hymerectomy with hemodynamic fluctuations after intraoperative injection of posterior pituitary lobes

Interventions

Group A:1 mg/kg lidocaine is injected during anesthesia induction
Group B:Injection of 0.05 ml/kg normal saline (equal milliliter amount of lidocaine) at anesthesia induction

Sponsors

The First Affiliated Hospital,Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who underwent elective laparoscopic myomectomy in our hospital; 2. ASA grading I-II; 3. Age 18-65 years old; 4. Voluntarily accept patient-controlled intravenous analgesia pump analgesia; 5. Voluntarily participate in this study, and communicate without barriers;

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to the use of lidocaine; 2. Those with a history of drug abuse or alcoholism; 3. Those who have participated in clinical trials related to lidocaine in the past; 4. Patients with ASA grade greater than or equal to grade III, abnormal preoperative vital organs or endocrine system, immune function, liver and kidney insufficiency, and coagulation dysfunction; 5. Patients with inflammation and fever and body infection before surgery; 6. Patients with preoperative mental problems (chronic depression or severe bipolar disorder); 7. Patients who are unable to communicate effectively with the investigator or refuse to participate in the experiment; 8. Patients with intraoperative blood loss exceeding 800ml or shock requiring a large amount of blood transfusion; 9. Patients with serious complications within 6 hours after surgery, such as delayed bleeding, multi-organ insufficiency or critically ill transfer to intensive care unit; 10. BMI >=35kg/?; 11. other factors that prevent patients from cooperating with the study protocol;

Design outcomes

Primary

MeasureTime frame
The degree of blood pressure fluctuation after posterior pituitary injection;

Secondary

MeasureTime frame
Immediate resting pain after extubation;Dose of vasoactive drug immediately from the start of surgery to extubation;Propofol dosage;The amount of analgesic medication used immediately from the start of surgery to extubation;Incidence of sore throat within 30 minutes after extubation;Incidence of cough immediately after extubation;off-bed time;The time to persistently elevate mean arterial pressure after intraoperative injection of posterior pituitary phyllin;

Countries

China

Contacts

Public ContactDuan Xiaoyun

The First Affiliated Hospital,Sun Yat-sen University

duanxyunfg@163.com+86 18565065185

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026